Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
| Autor: | Simona Zipursky, Manish M. Patel, Chantal Laroche Veira, Lee M. Hampton, Yann Folly, Alejandro Ramirez Gonzalez, Margaret Farrell, Emily Wootton, Tasleem Kachra, Feyrouz Kurji |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
IPV routine immunization polio Context (language use) IMG inactivated polio vaccine computer.software_genre Global Health vaccine introduction 03 medical and health sciences 0302 clinical medicine Systems management Poliomyelitis eradication medicine Global health Immunology and Allergy Humans 030212 general & internal medicine Disease Eradication vaccine supply Strategic planning business.industry Immunization Programs computer.file_format endgame Public relations vaccines medicine.disease oral polio vaccine Virology Poliomyelitis Poliovirus Vaccine Inactivated 030104 developmental biology Infectious Diseases vaccine shortage Poliovirus Vaccine Oral Supplement Article business computer polio eradication |
| Zdroj: | The Journal of Infectious Diseases |
| ISSN: | 1537-6613 |
| Popis: | The Immunization Systems Management Group (IMG) was established as a time-limited entity, responsible for the management and coordination of Objective 2 of the Polio Eradication and Endgame Strategic Plan. This objective called for the introduction of at least 1 dose of inactivated polio vaccine (IPV) into the routine immunization programs of all countries using oral polio vaccine (OPV) only. Despite global vaccine shortages, which limited countries’ abilities to access IPV in a timely manner, 105 of 126 countries using OPV only introduced IPV within a 2.5-year period, making it the fastest rollout of a new vaccine in history. This achievement can be attributed to several factors, including the coordination work of the IMG; high-level engagement and advocacy across partners; the strong foundations of the Expanded Programme on Immunization at all levels; Gavi, the Vaccine Alliance’s vaccine introduction experiences and mechanisms; innovative approaches; and proactive communications. In many ways, the IMG’s work on IPV introduction can serve as a model for other vaccine introductions, especially in an accelerated context. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|